PNC Financial Services Group’s Calithera Biosciences, Inc CALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-55
Closed -$4K 4161
2019
Q2
$4K Hold
55
﹤0.01% 3806
2019
Q1
$7K Hold
55
﹤0.01% 3692
2018
Q4
$4K Hold
55
﹤0.01% 3775
2018
Q3
$6K Buy
55
+5
+10% +$476 ﹤0.01% 3802
2018
Q2
$5K Hold
50
﹤0.01% 3854
2018
Q1
$6K Hold
50
﹤0.01% 3867
2017
Q4
$8K Hold
50
﹤0.01% 3764
2017
Q3
$16K Hold
50
﹤0.01% 3502
2017
Q2
$15K Hold
50
﹤0.01% 3440
2017
Q1
$12K Buy
+50
New +$8.64K ﹤0.01% 3474
2016
Q3
Hold
0
4374
2016
Q2
Hold
0
4574
2016
Q1
Hold
0
4606
2015
Q4
Hold
0
4620
2015
Q3
Sell
-500
Closed -$64.8K 4735
2015
Q2
$71K Buy
+500
New +$116K ﹤0.01% 2832
2015
Q1
Hold
0
4787

Other funds holding CALA

PNC Financial Services Group's CALA Position: Q3 2019 in Review

PNC Financial Services Group sold out of Calithera Biosciences, Inc (CALA) in Q3 2019, closing a stake of 55 shares — an estimated $4K sold.

PNC Financial Services Group first reported a position in CALA in Q2 2015 and held it in 11 quarters. The position peaked at $71K in Q2 2015. 85 funds tracked by Wall St. Rank hold CALA as of Q3 2019.

  • PNC Financial Services Group reported no remaining Calithera Biosciences, Inc position as of Q3 2019 after selling out during the quarter.
  • PNC Financial Services Group sold 55 Calithera Biosciences, Inc shares in Q3 2019, an estimated $4K.
  • PNC Financial Services Group first reported a position in Calithera Biosciences, Inc in Q2 2015 and held it in 11 quarters.
  • PNC Financial Services Group's Calithera Biosciences, Inc position peaked at $71K in Q2 2015.
  • 85 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2019.

Based on PNC Financial Services Group's 13F filing for Q3 2019, filed 8 Nov 2019.